IMPACT International GmbH products

ONE SYSTEM – MANY THERAPEUTIC OPTIONS. The innovative technology of IMPACT permits the preparation of variable concentrations of leukocytes and thrombocytes. And that, by means of a very simple automated preparation process. Scientifically tested IMPACT programs with specific parameters are recommended for each therapeutic goal. In addition, the system also permits the physician to define and store own program variants. Modern personalized medicine to customize treatment options to each patient‘s needs. RELIABLE TECHNOLOGY FOR REPRODUCIBLE RESULTS. IMPACT centrifuges and separates the requested blood fractions fully automated and in a closed system. The integral optical sensor separates reliably and precisely. The syringe with the patient’s blood is laid in, and after the program has been completed, the requested autologous blood product is removed and “ready-to-use”.

Autologous cell therapies make use of the natural endogenous mechanisms for the regeneration and healing of injured tissue. The body’s response to an injury is a complex healing cascade in order to heal the wound as quickly as possible. To understand how this regeneration process works, let us take a look into the cellular level.

For the production of an autologous conditioned serum

With anticoagulant for the production of highly concentrated platelet concentrate

Without anticoagulant for the production of slightly concentrated platelet-rich plasma